{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:16:41Z","timestamp":1788376601239,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"vor","delay-in-days":837,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.rmed.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T23:19:51Z","timestamp":1363648791000},"page":"890-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis"],"prefix":"10.1016","volume":"107","author":[{"given":"Isabel C.","family":"Mira-Avendano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Parambil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Arrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2013.02.015_bib1","first-page":"291","article-title":"Non-neoplastic disorders of the lower respiratory tract","author":"Travis","year":"2002","journal-title":"Armed Forces Institute of Pathology First series. Fascicle 2."},{"key":"10.1016\/j.rmed.2013.02.015_bib2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"25","key":"10.1016\/j.rmed.2013.02.015_bib3","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.rmed.2013.02.015_bib4","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, randomized double blind placebo-controlled trial of corticosteroids and intravenous cyclophophamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Hoyles","year":"2006","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.015_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/ecp.12.9","article-title":"Treatment of interstitial lung diseases associated with connective tissue diseases","volume":"5","author":"Kobayashi","year":"2012","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.015_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2012.01.003","article-title":"Treatment of systemic sclerosis complications: what to use when first line treatment fails \u2013a consensus of systemic sclerosis experts","volume":"42","author":"Walker","year":"2012","journal-title":"Seminars Arthritis & Rheumatism"},{"key":"10.1016\/j.rmed.2013.02.015_bib7","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/S0140-6736(03)14862-3","article-title":"Diagnostic criteria for polymiositis and dermatomyosits","volume":"362","author":"Miller","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.rmed.2013.02.015_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in scleroderma: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"American Journal of Respiratory Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.015_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general US population (NHANES III)","volume":"159","author":"Hankinson","year":"1999","journal-title":"American Journal of Respiratory Critical Care Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.bor.0000179949.65895.53","article-title":"Interstitial lung disease in polymyositis-dermatomyositis","volume":"17","author":"Fathi","year":"2005","journal-title":"Current Opinion in Rheumatology"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.015_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-985666","article-title":"Pulmonary complications of polymyositis-dermatomyositis","volume":"28","author":"Fathi","year":"2007","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis-dermatomyositis and anti-pm-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"British of Dermatology"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.015_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis-dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.rmed.2013.02.015_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymiositis-Dermatomyositis associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"American Journal Respiratory Critical Care Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","article-title":"PM\/DM associated lung disease: analysis of series of 81 patients","volume":"14","author":"Selva-O'Collaghan","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.rmed.2013.02.015_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/sarh.2002.50012","article-title":"Interstitial lung disease in polymyositis-dermatomyositis: clinical course and response to treatment","volume":"32","author":"Schnabel","year":"2003","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.rmed.2013.02.015_bib17","first-page":"260","article-title":"HRCT characterization of ILD in PM\/DM","volume":"35","author":"Hayashi","year":"2008","journal-title":"The Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.015_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.210.2.r99ja15333","article-title":"Interstitial lung disease in association with polymyositis-dermatomysitis: long-term follow up CT evaluation in seven patients","volume":"210","author":"Akira","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.rmed.2013.02.015_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2169\/internalmedicine.41.1135","article-title":"Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis-dermatomyosits","volume":"41","author":"Yang","year":"2002","journal-title":"Internal Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib20","first-page":"1045","article-title":"Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomysitis-polymyositis","volume":"14","author":"Gruhn","year":"1987","journal-title":"J Rheumatology"},{"key":"10.1016\/j.rmed.2013.02.015_bib21","first-page":"254","article-title":"Early intervention with corticosteroids and cyclosporine-A and 2-hour post dose blood concentration monitoring improves the prognosis of acute\/subacute interstitial pneumonia in dermatomyositis","volume":"35","author":"Kotani","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.rmed.2013.02.015_bib22","first-page":"371","article-title":"Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporine A","volume":"43","author":"Koboyashi","year":"2003","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.015_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/ajrccm\/141.3.727","article-title":"Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis correlated with histology findings","volume":"141","author":"Tezelaar","year":"1990","journal-title":"American Review of Respiratory Disease"},{"key":"10.1016\/j.rmed.2013.02.015_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2169\/internalmedicine.38.733","article-title":"Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis","volume":"38","author":"Yoshida","year":"1999","journal-title":"Internal Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2169\/internalmedicine.36.519","article-title":"Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide treatment","volume":"36","author":"Shinohara","year":"1997","journal-title":"Internal Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib26","first-page":"1719","article-title":"Combination treatment with corticosteroids, cyclosporine A and intravenous pulse of cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.015_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.39.428","article-title":"Successful combined therapy of cyclophosphamide for acute exacerbated interstitial pneumonia associated with dermatomyositis","volume":"39","author":"Tanaka","year":"2000","journal-title":"Internal Medicine"},{"key":"10.1016\/j.rmed.2013.02.015_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide treatment for progressive interstitial pneumonia in patients with polymyositis-dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2013.02.015_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03009740310002542","article-title":"Successful treatment of dermatomyositis related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine","volume":"32","author":"Mok","year":"2003","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.rmed.2013.02.015_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate is safe, well tolerated and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2013.02.015_bib31","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","article-title":"Mycophenolate mofetil for interstitial lung disease in dermatomyositis","volume":"62","author":"Morgannoth","year":"2010","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.rmed.2013.02.015_bib32","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory polymyositis with interstitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.015_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08916930500124023","article-title":"Therapeutic approach with T-cell-specific immunosuppesants","volume":"38","author":"Takada","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rmed.2013.02.015_bib34","first-page":"707","article-title":"Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis-dermatomyositis","volume":"23","author":"Ochi","year":"2005","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.015_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","article-title":"Anti-Jo1 positive polymyositis. Successful therapy with leflunomide","volume":"39","author":"Lange","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rmed.2013.02.015_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-009-9146-6","article-title":"Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis and dermatomyositis","volume":"187","author":"Suzuki","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2013.02.015_bib37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome. A retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:28:39Z","timestamp":1760614119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611113000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0954611113000644"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2013.02.015","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2013.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}